HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lisann Pelzl Selected Research

Neuroacanthocytosis

5/2021Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
1/2021Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis.
1/2020Decreased Na+/K+ ATPase Expression and Depolarized Cell Membrane in Neurons Differentiated from Chorea-Acanthocytosis Patients.
1/2018Inhibition of Lithium Sensitive Orai1/ STIM1 Expression and Store Operated Ca2+ Entry in Chorea-Acanthocytosis Neurons by NF-κB Inhibitor Wogonin.
1/2017Lithium Sensitive ORAI1 Expression, Store Operated Ca2+ Entry and Suicidal Death of Neurons in Chorea-Acanthocytosis.
1/2017Lithium Sensitivity of Store Operated Ca2+ Entry and Survival of Fibroblasts Isolated from Chorea-Acanthocytosis Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lisann Pelzl Research Topics

Disease

6Thrombosis (Thrombus)
11/2022 - 08/2012
6Neuroacanthocytosis
05/2021 - 01/2017
5COVID-19
11/2022 - 01/2021
5Thrombocytopenia (Thrombopenia)
01/2022 - 08/2019
4Neoplasms (Cancer)
01/2019 - 01/2017
2Infections
01/2022 - 01/2021
2Hemorrhage
01/2021 - 01/2020
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2017
2Chronic Renal Insufficiency
01/2020 - 01/2018
2Carcinoma (Carcinomatosis)
01/2019 - 01/2015
1Thromboinflammation
01/2022
1Rare Diseases (Rare Disease)
05/2021
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2021
1Neuroinflammatory Diseases
01/2021
1Inflammation (Inflammations)
01/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019
1Hypoxia (Hypoxemia)
01/2019
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Vascular Calcification
01/2018
1Ischemia
01/2018
1Hyperphosphatemia
01/2018
1Acidosis
01/2018
1Dehydration (Water Stress)
01/2017
1Prostatic Neoplasms (Prostate Cancer)
01/2017
1Medulloblastoma
01/2017
1Vascular System Injuries
01/2013
1Hypertension (High Blood Pressure)
01/2013
1Vascular Diseases (Vascular Disease)
01/2013
1Cardiomegaly (Heart Hypertrophy)
05/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2012
4Immunoglobulin G (IgG)IBA
11/2022 - 01/2021
4IntegrinsIBA
01/2022 - 08/2012
4LithiumIBA
01/2020 - 01/2017
3Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 08/2019
3VaccinesIBA
01/2022 - 01/2021
3Phosphotransferases (Kinase)IBA
05/2021 - 01/2020
3Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2017
3ThrombinFDA Link
01/2017 - 08/2012
2Fc gamma receptor IIAIBA
01/2022 - 01/2022
2AntibodiesIBA
01/2022 - 08/2019
2Platelet Factor 4IBA
01/2022 - 08/2019
2Phosphates (Orthophosphate)IBA
01/2020 - 01/2018
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 01/2018
22- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA
01/2017 - 01/2015
1Iloprost (Ventavis)FDA Link
11/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1Antigen-Antibody Complex (Immune Complex)IBA
01/2022
1LipidsIBA
01/2022
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2022
1Fondaparinux (Arixtra)FDA Link
01/2022
1danaparoid (Orgaran)FDA Link
01/2022
1argatroban (MPQA)FDA Link
01/2022
1PhosphatidylserinesIBA
01/2022
1AnticoagulantsIBA
01/2022
1nilotinibFDA Link
01/2021
1tau Proteins (tau Protein)IBA
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1AutoantibodiesIBA
01/2021
1ChAdOx1 nCoV-19IBA
01/2021
1COVID-19 VaccinesIBA
01/2021
1SynucleinsIBA
01/2021
1GlucocorticoidsIBA
01/2020
1Adenosine Triphosphatases (ATPase)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Ellagic AcidIBA
01/2019
1Antisense OligonucleotidesIBA
01/2019
1Hydrolyzable TanninsIBA
01/2019
1ConnectinIBA
01/2019
1Calcitriol (Calcijex)FDA LinkGeneric
01/2018
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2018
1CalciumIBA
01/2018
1Hormones (Hormone)IBA
01/2018
1wogoninIBA
01/2018
1SaltsIBA
01/2018
1Ammonium CompoundsIBA
01/2018
1calcium phosphateIBA
01/2018
1Bicarbonates (Hydrogen Carbonate)IBA
01/2018
1Cholecalciferol (Vitamin D3)FDA Link
01/2018
1Annexin A5IBA
01/2017
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2017
1ORAI1 ProteinIBA
01/2017
1IstaroximeIBA
01/2017
1collagen-related peptideIBA
01/2017
1Caspase 3 (Caspase-3)IBA
01/2017
1Cisplatin (Platino)FDA LinkGeneric
01/2015
1Ion Channels (Ion Channel)IBA
01/2015
1MineralocorticoidsIBA
01/2013
1CateninsIBA
05/2012
1hydroxide ionIBA
09/2011
1Vitamin DFDA LinkGeneric
09/2011

Therapy/Procedure

4Therapeutics
01/2020 - 01/2015
1Ligation
11/2022
1Platelet Transfusion (Blood Platelet Transfusions)
01/2020